Inactive Instrument

Immunosyn Corp Share Price

Stocks

End-of-day quote Other OTC
- ^USD	-

30/-1/30	IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	PR

Manager	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	75	15/10/2007
Douglas A. McClain DFI	Director of Finance/CFO	51	-

Director	Title	Age	Since
Stephen D. Ferrone BRD	Director/Board Member	75	09/07/2011
Douglas A. McClain CHM	Chairman	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+3.19%	+11.31%	+64.28%	+155.91%	1,26300Cr
JOHNSON & JOHNSON	-0.73%	+3.56%	+44.65%	+84.17%	66TCr
ABBVIE INC.	+1.41%	+3.24%	+35.25%	+108.88%	52TCr
ROCHE HOLDING AG	+0.42%	+3.20%	+55.81%	+72.50%	39TCr
MERCK & CO., INC.	+2.18%	+2.93%	+73.90%	+45.59%	37TCr
NOVARTIS AG	+1.12%	+4.52%	+34.76%	+58.24%	31TCr
ASTRAZENECA PLC	+6.96%	+8.86%	+11.95%	+36.20%	29TCr
AMGEN INC.	+1.15%	+6.09%	+56.15%	+82.25%	25TCr
GILEAD SCIENCES, INC.	+3.06%	+9.38%	+42.48%	+117.32%	21TCr
Average	+2.08%	+5.90%	+46.58%	+84.56%	47.35TCr
Weighted average by Cap.	+2.01%	+6.60%	+50.51%	+100.44%

Employees

Sector